News Shortcuts from other journals

New treatment for sepsis disappointing in children

BMJ 2007; 334 doi: (Published 22 March 2007) Cite this as: BMJ 2007;334:608

Drotrecogin alfa, a recombinant human activated protein C, is a new treatment for severe sepsis. At least one trial has shown that it reduces mortality in adults, so researchers were “profoundly disappointed” to find that it may not work so well, if at …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial